Luke Smith represents companies across the nation in complex litigation and antitrust compliance. He provides antitrust counseling and analysis in proposed mergers and acquisitions, including Hart-Scott Rodino Act (HSR) pre-merger filing notifications. Other clients, primarily healthcare companies, have benefited from Luke’s knowledge of industry-specific antitrust issues, including clinical integration, accountable care organizations, payor/provider negotiations, and healthcare joint ventures. During the past five years, Luke has advised on transactions worth more than $12 billion, two thirds of which were in the healthcare industry.
American Bar Association, Antitrust Section
American Health Lawyers Association (AHLA)
Represented Wright Medical Group in its acquisition of Cartiva, Inc.
Represented BluSky Restoration in its sale to Dominus Capital.
Represented Envision Healthcare in its definitive agreement to sell to KKR for $9.9 billion
Represented NN, Inc. (Nasdaq: NNBR) in its acquisition of Paragon Medical
Represented AAC Holdings, Inc., parent company of American Addiction Centers, in its acquisition of AdCare, Inc.
Represented a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary of a leading pharmacy healthcare provider
Represented Bob Evans Farms, Inc. (Nasdaq:BOBE) in its acquisition by Post Holdings, Inc.
Represented IMA Consulting in its sale to New Mountain Capital
Represented CenseoHealth in its sale to New Mountain Capital
Represented Tennessee Steel Haulers, Inc. in its sale to Daseke, Inc.
Vanderbilt Law Review